Two novel heterozygous HTRA1 mutations in two pedigrees with cerebral small vessel disease families

Wen-Ying Zhang1, Fei Xie1, Pei-Lin Lu2

  • 1Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China.

Insights

Two novel heterozygous HTRA1 gene mutations cause hereditary cerebral small vessel disease (CSVD). Males showed symptoms, while females were asymptomatic, suggesting potential sex-based differences in this genetic disorder.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Hereditary cerebral small vessel disease (CSVD) is increasingly linked to genetic factors.
  • Mutations in the High-temperature requirement A serine peptidase 1 (HTRA1) gene are a recently identified cause of autosomal dominant CSVD.

Observation:

  • This study details clinical and neuroimaging findings in two families with hereditary CSVD.
  • Two distinct heterozygous HTRA1 mutations, a missense variant (p.V176A) and a nonsense variant (p.R197X), were identified in the probands.
  • Co-segregation analysis confirmed mutation inheritance within families.

Findings:

  • All affected males carrying heterozygous HTRA1 mutations exhibited characteristic CSVD clinical and neuroimaging features.
  • Conversely, all affected females with heterozygous HTRA1 mutations were clinically and neuroimaging asymptomatic.
  • This suggests a potential male predominance in the manifestation of CSVD associated with heterozygous HTRA1 mutations.

Implications:

  • HTRA1 gene screening is recommended for individuals diagnosed with familial CSVD.
  • The observed sex-based difference in clinical presentation warrants further investigation.
  • Understanding these genetic underpinnings can improve diagnostic strategies and patient management for hereditary CSVD.